Crolius Clayton
- SEC CIK
- 0001937013
No open-market purchases or sales filed in the past year.
Current role at each company
- SONM DNA X, Inc.Chief Financial Officeras of Feb 10, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Crolius Clayton as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 25, 2025 (view filing) | Apr 23 | 2 days | Crolius ClaytonChief Financial Officer | SSale | −11.6K | $1.45 | −$16.9K | −27.3%31.0K after | |
| Sep 18, 2023 (view filing) | Sep 15 | 3 days | Crolius ClaytonChief Financial Officer | PPurchase | +86.7K | $0.68 | +$59.0K | New position86.7K after |